Global Infectious Disease Treatment Market 2014-2018

Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defence system or can directly target the causative agent.

Analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 3.43 percent over the period 2013-2018.

The Report recognizes the following companies as the key players in the Global Infectious Disease Treatment Market: F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc. and Pfizer Inc.

Other Prominent Vendors in the market are: AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, Novartis, pSivida and Sanofi.

One of the emerging trends in this market is the emergence of Interferon-free regimens. Various all-oral, IFN-free regimens are under development and are expected to attain higher sustained virologic response and cause fewer side effects than the currently approved therapies.

Inquire on the Report at http://www.sandlerresearch.org/inquire-before-buying?rname=22745

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Infectious Disease Treatment market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various drugs administered to treat various infectious diseases caused by bacteria, virus, fungi, and parasites, which include:

• Antibacterial drugs (beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, sulfonamides, tetracyclines, and other antibacterials)
• Antiviral drugs (HIV, hepatitis C, hepatitis B, and other antivirals)
• Antifungal drugs (azoles, pyrimidines, echinodians, polyenes, allylamines, and other antifungal drugs)
• Antiparasitic drugs

Global Infectious Disease Treatment Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Infectious Disease Treatment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. According to the report, the launch of Direct-acting Antivirals is one of the major drivers for the Global Infectious Disease Treatment market. DAAs are administered in combination with other antiviral drugs such as ribavirin and PEG-IFN and increase the efficacy of treatment and decrease the duration of therapy and this leads to increased preference for this treatment among patients.

Further, the report states that a generic erosion of marketed drugs is one of the major challenges faced by the market. A loss of patent protection and market exclusivity generally triggers the entry of low-cost alternatives for drugs, which, in turn, decreases the sales of innovator-approved drugs.

Get discount on the Report at http://www.sandlerresearch.org/discount?rname=22745

Worldwide Asthma Market Growth Report and 2018 Forecast

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.

Analysts forecast the Global Asthma Market to grow at a CAGR of 4.50 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Asthma market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various class of drugs used in the treatment of asthma:

·         • Bronchodilators

·         • Leukotriene antagonists

·         • Mast cell stabilizers

·         • Immunosuppressants

Global Asthma Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Asthma Market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=22929 .

Global Healthcare Information Systems Industry Insights and 2018 Forecast Report

A healthcare information system is an integrated system designed for capturing, storing, managing, and transmitting information related to the health of individuals. This system helps end-users to make informative decisions. It collects data from healthcare facilities and analyzes these data to ensure their overall quality, relevance, and timeliness and converts them into information for health-related decision making. Globally, the aging population is the major end-users of healthcare information systems.

Analysts forecast the Global Healthcare Information System market to grow at a CAGR of 7.44 percent over the period 2013-2018.

Covered in this Report

The report covers the present scenario and the growth prospects of the Global Healthcare Information System market for the period 2014-2018. In terms of product, the Global Healthcare Information System market is segmented into three: Hospital Information System, Laboratory Information System, and Pharmacy Information System.

Global Healthcare Information System Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Global Healthcare Information System market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=22946 .

Global SaaS Security Market 2014-2018

SaaS security is a type of IT security deployment that makes use of cloud computing technology. SaaS security services involve a range of applications provided by the service provider to customer organizations through the cloud network. These services are provided on a subscription basis, which involves no fixed cost to the organization as the service is rendered online. Growing cyber-attacks, sophisticated threats, and government mandates have forced enterprises to look for security solutions that can effectively secure their business and brand. SaaS security provides quick tangible benefits which have helped it to grow globally amid increased deployments of on-premises systems.

Analysts forecast the Global SaaS Security market to grow at a CAGR of 20.1 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global SaaS Security market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the services provided by SaaS security software vendors.

The market is highly fragmented with the presence of a large number of small and large vendors. Therefore, the report does not provide the market share of the vendors; it only lists the key vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global SaaS Security market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The report highlights major market segments, such as:

·         • Email Gateway Services

·         • IAM Services

·         • Cloud Encryption Services

·         • Web Gateway Services

·         • Remote Vulnerabilities Management Services

·         • SIEM Services

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=22944 .